Published in Br J Obstet Gynaecol on February 01, 1990
Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial. Pilot Feasibility Stud (2016) 1.40
Progesterone supplementation and the prevention of preterm birth. Rev Obstet Gynecol (2011) 1.11
A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study. J Matern Fetal Neonatal Med (2009) 1.09
Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins. Am J Obstet Gynecol (2007) 1.06
Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. Obstet Gynecol (2009) 1.05
Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth. Am J Obstet Gynecol (2013) 1.05
Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth. J Matern Fetal Neonatal Med (2011) 1.02
Recurrent preterm birth. Semin Perinatol (2007) 0.95
Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle. Am J Obstet Gynecol (2010) 0.88
Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial. BMC Pregnancy Childbirth (2007) 0.84
Association between HIV in pregnancy and antiretroviral therapy, including protease inhibitors and low birth weight infants. Infect Dis Obstet Gynecol (2000) 0.82
Endocrinology of parturition. Indian J Endocrinol Metab (2013) 0.82
Progestin treatment for the prevention of preterm birth. Acta Obstet Gynecol Scand (2011) 0.81
Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety. Ther Clin Risk Manag (2009) 0.81
Gestational exposure to variable stressors produces decrements in cognitive and neural development of juvenile male and female rats. Curr Top Med Chem (2011) 0.80
The management of preterm labour. Arch Dis Child Fetal Neonatal Ed (2007) 0.80
Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: A randomized placebo-controlled double-blind study. Int J Reprod Biomed (Yazd) (2016) 0.79
17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial. BMC Res Notes (2011) 0.79
Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations. Semin Perinatol (2014) 0.78
Blood pH and gases in fetuses in preterm labor with and without systemic inflammatory response syndrome. J Matern Fetal Neonatal Med (2011) 0.77
Human decidual cell Toll-like receptor signaling in response to endotoxin: the effect of progestins. Am J Obstet Gynecol (2007) 0.77
17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study. Am J Obstet Gynecol (2017) 0.76
Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth. Facts Views Vis Obgyn (2012) 0.75
What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth. Semin Perinatol (2016) 0.75
Resurrection of preterm labor drug evokes questions of fairness. Biotechnol Healthc (2011) 0.75
Natural Micronized Progesterone Sustained Release (SR) and Luteal Phase: Role Redefined!! J Clin Diagn Res (2016) 0.75